Hjem › Brystkreft › California › Mountain View
Kliniske studier for Brystkreft i Mountain View, CA
26 studier for Brystkreft søker deltakere på steder i og rundt Mountain View (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruttererFase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi unna
A Study of PHST001 in Advanced Solid Tumors
RekruttererFase 1
- Stanford University School of Medicine, Palo Alto · 5 mi unna
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruttererFase 3
- El Camino Hospital, Mountain View
- Palo Alto Medical Foundation, Mountain View
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
RekruttererFase 1/2
- Stanford Medicine Cancer Center, Stanford · 5 mi unna
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
- Stanford University Medical Center, Stanford · 5 mi unna
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
- Stanford University Medical Center, Stanford · 5 mi unna
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruttererFase 3
- Stanford Cancer Center, Palo Alto · 5 mi unna
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruttererFase 3
- Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · 5 mi unna
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi unna
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
RekruttererFase 1
- Stanford University Hospital, Stanford · 5 mi unna
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RekruttererFase 3
- Research Site, Palo Alto · 5 mi unna
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
RekruttererFase 2
- Stanford Cancer Institute, Palo Alto · 5 mi unna
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruttererFase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi unna
- og 1 flere
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
RekruttererFase 2
- Stanford University, Stanford · 5 mi unna
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekruttererFase 2/3
- Local Institution - 0358, Stanford · 5 mi unna
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruttererFase 3
- Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · 5 mi unna
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RekruttererFase 1
- Stanford University Medical Center, Palo Alto · 5 mi unna
Magnetic Resonance Imaging of Breast Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Stanford University School of Medicine, Stanford · 5 mi unna
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
RekruttererObservasjonsstudie
- Stanford University School of Medicine, Stanford · 5 mi unna
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi unna
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi unna
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RekruttererFase 1
- Stanford Cancer Institute, Stanford · 5 mi unna
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Rekrutterer
- Stanford University, Stanford · 5 mi unna
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruttererObservasjonsstudie
- Stanford Cancer Institute, Palo Alto · 5 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Stanford · 5 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Mountain View
- Kreft (alle typer)40 studier
- Metastatisk kreft25 studier
- Ikke-småcellet lungekreft21 studier
- Akut myelogen leukemi19 studier
- Eggstokkreft19 studier
- Autismespekterforstyrrelse17 studier
- Lungekreft17 studier
- Prostatakreft15 studier
- Hjertesvikt15 studier
- Autisme13 studier
- Akut lymfoblastisk leukemi13 studier
- Kolorektal kreft13 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.